LQDA - NASDAQ

Liquidia Corporation

LQDA·NASDAQ

$55.69

+1.5%

HealthcareBiotechnology

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$4.95B

EPS-0.8000

P/E Ratio-69.61

Earnings Date08/11/2026

lqda

Total Current Liabilities

Last Annual Value

135.77M

3-Year CAGR

149%

5-Year CAGR

63%

10-Year CAGR

27%

Adjust for Inflation

Liquidia Corporation Competitors Analysis of Total Current Liabilities

LQDA · NASDAQ

Company	Total Current Liabilities	CAGR 3Y	CAGR 5Y	CAGR 10Y
Liquidia Corporation NASDAQ:LQDA	135.77M	94.2%	79.3%	27.4%
Cogent Biosciences, Inc. NASDAQ:COGT	63.95M	18.8%	30.2%	22.0%
Structure Therapeutics Inc. NASDAQ:GPCR	63.28M	36.8%	48.9%	N/A
Denali Therapeutics Inc. NASDAQ:DNLI	98.35M	8.0%	-23.6%	26.9%
89bio, Inc. NASDAQ:ETNB	36.13M	6.9%	13.1%	N/A
ImmunityBio, Inc. NASDAQ:IBRX	61.75M	1.9%	-30.1%	17.3%
Arcus Biosciences, Inc. NYSE:RCUS	231.00M	7.9%	6.8%	45.2%
Ocular Therapeutix, Inc. NASDAQ:OCUL	50.81M	13.3%	14.0%	19.9%
Agios Pharmaceuticals, Inc. NASDAQ:AGIO	82.21M	6.6%	6.6%	-0.7%

Liquidia Corporation Fair Value Envelope

LQDA · NASDAQ

Our analysis suggests that LQDA has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $55.69, this represents a potential HIDDEN relative to our calculated worth for Liquidia Corporation.

HIDDEN

Intrinsic Value

Current Price: $55.69

Related Guides

Blog Categories

Continue your LQDA research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.